Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Serum levels and urinary excretion in rats, rabbits and dogs.
D000284:Administration, Oral; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000097:blood* / Q000652:urine; D002849:Chromatography, Gas; D004285:Dogs; D005260:Female; D006207:Half-Life; D007273:Injections, Intramuscular; D007274:Injections, Intraperitoneal; D008297:Male; D010653:Phenylbutazone / Q000008:administration & dosage / Q000097:blood / Q000652:urine; D011485:Protein Binding; D011720:Pyrazoles / Q000008:administration & dosage / Q000097:blood* / Q000652:urine; D011817:Rabbits; D051381:Rats; D013053:Spectrophotometry; D013729:Terpenes / Q000008:administration & dosage / Q000097:blood* / Q000652:urine; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D011720:Pyrazoles; D013729:Terpenes; D010653:Phenylbutazone